Modified-Release Drug Delivery Systems: Site-Targeted
Phase Contrast and Differential Interference Contrast Microscopy
Properties of Enantiomers and Optical Activity
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: May 15, 2026

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
Published on: September 3, 2013
Jeong Heon Lee1, Gwangli Park, Gloria H Hong
1Division of Hematology/Oncology, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA; ; Center for Molecular Imaging, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA.
Developing optimal targeted contrast agents is crucial for improving image-guided cancer surgery. This review discusses key design considerations for these agents to enhance in vivo performance for better diagnosis and therapy.
13:21Preparation, Purification, and Characterization of Lanthanide Complexes for Use as Contrast Agents for Magnetic Resonance Imaging
Published on: July 21, 2011
10:47Harnessing the Bioorthogonal Inverse Electron Demand Diels-Alder Cycloaddition for Pretargeted PET Imaging
Published on: February 3, 2015
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: